Quick Takeaways
- Braeden Lichti filed SCHEDULE 13G for Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share.
- Disclosed ownership: 5%.
- Date of event: 05 Feb 2026.
Braeden Lichti - 05 Feb 2026 SCHEDULE 13G Report for Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share
- Filing Manager
- Braeden Lichti
- Reporting Manager
- Braeden Lichti
- Shares outstanding
- 708,583 shares
- Disclosed Ownership
- 35,500 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 05 Feb 2026, 21:42:50 UTC
- Date of event
- 05 Feb 2026
- Next filing
- 11 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Braeden Lichti disclosed 5% ownership in Bluejay Diagnostics, Inc. Common Stock, $0.0001 par value per share on 05 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2026, 21:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Braeden Lichti | 5% | 35,500 | 24,500 | 11,000 | /s/ Braeden Lichti | Braeden Lichti | |
| Northstrive Fund II LP | 1.6% | 11,000 | 0 | 11,000 | /s/ Braeden Lichti | Braeden Lichti, Manager |